Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shimatsu

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Clinical & Developmental Immunology|January 11, 2013
Macroprolactinemia: diagnostic, clinical, and pathogenic significanceAkira Shimatsu, Naoki Hattori
Endocrine Journal|September 10, 2023
Proposed reference intervals of serum insulin-like growth factor-1 (IGF-1) levels in older Japanese populationsTsuyoshi Isojima, Akira Shimatsu
Endocrine Journal|October 19, 2010
Is there an undiscovered neurocircuit for regulating GH secretion? -Pitfalls of GHRP-2 and ITT as GH provocative tests-Kyuzi Kamoi, Akira Shimatsu, Mai Kobayashi
European Journal of Endocrinology|October 7, 2015
Variability in the detection of macro TSH in different immunoassay systemsNaoki Hattori, Takashi Ishihara, Akira Shimatsu
Clinical Chemistry and Laboratory Medicine|October 13, 2015
A possible cause of the variable detectability of macroprolactin by different immunoassay systemsNaoki Hattori, Kohzo Aisaka, Akira Shimatsu
Endocrine Journal|November 21, 2009
Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entityAkira Shimatsu, Yutaka Oki, Ichiro Fujisawa, et al.
European Journal of Endocrinology|January 17, 2012
The natural history of macroprolactinaemiaNaoki Hattori, Takashi Adachi, Takashi Ishihara, et al.
Endocrine Journal|June 9, 2017
Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 studyShigeyuki Tahara, Mami Murakami, Tomomi Kaneko, et al.
Thyroid : Official Journal of the American Thyroid Association|June 27, 2018
Current Thyrotropin Immunoassays Recognize Macro-Thyrotropin Leading to Hyperthyrotropinemia in Females of Reproductive AgeNaoki Hattori, Kohzo Aisaka, Kazuhisa Chihara, et al.
Endocrine Journal|November 15, 2019
Long-term safety and treatment outcomes of pegvisomant in Japanese patients with acromegaly: results from the post-marketing surveillanceHiromi Yamaguchi, Akira Shimatsu, Akifumi Okayama, et al.
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Clinical & Developmental Immunology|January 11, 2013
Macroprolactinemia: diagnostic, clinical, and pathogenic significanceAkira Shimatsu, Naoki Hattori
Endocrine Journal|September 10, 2023
Proposed reference intervals of serum insulin-like growth factor-1 (IGF-1) levels in older Japanese populationsTsuyoshi Isojima, Akira Shimatsu
Endocrine Journal|October 19, 2010
Is there an undiscovered neurocircuit for regulating GH secretion? -Pitfalls of GHRP-2 and ITT as GH provocative tests-Kyuzi Kamoi, Akira Shimatsu, Mai Kobayashi
European Journal of Endocrinology|October 7, 2015
Variability in the detection of macro TSH in different immunoassay systemsNaoki Hattori, Takashi Ishihara, Akira Shimatsu
Clinical Chemistry and Laboratory Medicine|October 13, 2015
A possible cause of the variable detectability of macroprolactin by different immunoassay systemsNaoki Hattori, Kohzo Aisaka, Akira Shimatsu
Endocrine Journal|November 21, 2009
Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entityAkira Shimatsu, Yutaka Oki, Ichiro Fujisawa, et al.
European Journal of Endocrinology|January 17, 2012
The natural history of macroprolactinaemiaNaoki Hattori, Takashi Adachi, Takashi Ishihara, et al.
Endocrine Journal|June 9, 2017
Efficacy and safety of long-acting pasireotide in Japanese patients with acromegaly or pituitary gigantism: results from a multicenter, open-label, randomized, phase 2 studyShigeyuki Tahara, Mami Murakami, Tomomi Kaneko, et al.
Thyroid : Official Journal of the American Thyroid Association|June 27, 2018
Current Thyrotropin Immunoassays Recognize Macro-Thyrotropin Leading to Hyperthyrotropinemia in Females of Reproductive AgeNaoki Hattori, Kohzo Aisaka, Kazuhisa Chihara, et al.
Endocrine Journal|November 15, 2019
Long-term safety and treatment outcomes of pegvisomant in Japanese patients with acromegaly: results from the post-marketing surveillanceHiromi Yamaguchi, Akira Shimatsu, Akifumi Okayama, et al.
Pageof 21